Nope - Did not sell. I think they did not submit a manuscript until MUCH later than we had hoped, whether that is due to reanalysis using new GBM definition, some problem with data that required going back to individual sites (and covid impacts), wanting to wait until FDA formalized guidance on external controls, or whatever. If they submitted along the optimal publication timeline I had suggested, they would have had this published somewhere by now even under a worst case scenario (e.g., sending to 3 different journals). I still think the data will look good whenever they do come out, at least compared to external controls.
I loved the post recently about the guy's wife who saw a psychic saying TLD in March - that is as good a source of information as any!